Urovant Sciences and Sunovion Pharmaceuticals Launch Primary Care Co-Promotion of GEMTESA® (vibegron) for Patients with Overactive Bladder
Co-promotion extends sales and market access efforts to reach primary care physicians who treat OAB patients IRVINE, Calif. & BASEL,…